ADOR appoints Nadhim Zahawi to lead Advisory Board

ADOR Diagnostics appoints Nadhim Zahawi to lead its Advisory Board

Former Chancellor of the Exchequer and Vaccine Deployment Minister of the British Government and established global businessman to provide strategic guidance and advice as ADOR progresses towards commercialisation

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is delighted to announce that ADOR Diagnostics ("ADOR"), an associate company of the Group, has appointed the Rt. Hon Nadhim Zahawi as Chairman of its Advisory Board. Mr. Zahawi, who brings a wealth of experience in government and business, will provide strategic guidance and advice to support ADOR as it enters the next phase of its growth strategy to commercialise its extensive R&D and transform healthcare through cutting-edge diagnostic solutions.

• Zahawi began his career in business before co-founding YouGov in 2000, which became one of the world's largest polling and market research companies, having listed on the London Stock Exchange in 2005, and now employs over 400 people across three continents. In 2010, he became a Member of Parliament and held several roles in the British Government, including serving as Chancellor of the Exchequer, Secretary of State for Education and as Minister for COVID-19 Vaccine Deployment.

ADOR's NATlab molecular biology platform is currently undergoing pre-clinical validation at the Lazzaro Spallanzani National Institute for Infectious Diseases in Rome, Italy, a leading centre for infectious disease research and treatment. Successful completion of the pre-clinical validation is expected to enable initial sales of the NATlab and the commencement of the regulatory process under the European Union In Vitro Diagnostic Medical Device Regulation to become eligible for sale in the EU market.

Moti Nagar, Chief Executive Officer of BATM, said: "We are thrilled that Nadhim Zahawi has joined the Advisory Board at ADOR. His wealth of experience and success across both private enterprise and government, including from his time working on the UK's COVID vaccine rollout, will be invaluable as ADOR progresses to the next stage in its journey to commercialise its disruptive diagnostic solutions that aim to transform how disease is detected and managed. This is a very exciting moment for ADOR and we look to the future with great confidence."

Rt. Hon Nadhim Zahawi commented: "I am delighted to join ADOR to chair its Advisory Board. The potential for health tech to change the world is only just starting to be grasped. For individuals and for families, ADOR Diagnostics provides a concrete opportunity for a healthier, better life and a release from suffering and concern. For whole nations struggling under ever-increasing healthcare budgets, they will provide amazing tools to help transform treatment. I saw the impact great healthcare innovations have through the COVID pandemic, and am excited to help ADOR take the fight to disease and ill health and change face of diagnosis."